Clinical Trial Update: A Phase 2a Study, Effect of Vancomycin With vs Without Delpazolid (LCB01-0371) in Patients With MRSA Bacteremia [Phase 2]

View source ↗

Summary

A Phase 2a trial comparing vancomycin with vs without the investigational delpazolid (LCB01-0371) in Methicillin-resistant Staphylococcus aureus bacteremia was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Bacteremia

Drugs mentioned

• Vancomycin (vancomycin)
• delpazolid (delpazolid)

Snippet

Sponsor: LigaChem Biosciences, Inc. | Conditions: MRSA Bacteremia | Phase 2 | Status: TERMINATED | Results posted: 2025-05-06